Home>>Signaling Pathways>> Cancer Biology>>6-Chloropurine Riboside

6-Chloropurine Riboside (Synonyms: NSC 4910)

Catalog No.GC49551

A nucleoside precursor

Products are for research use only. Not for human use. We do not sell to patients.

6-Chloropurine Riboside Chemical Structure

Cas No.: 5399-87-1

Size Price Stock Qty
1 g
$69.00
In stock
5 g
$260.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

6-Chloropurine riboside is a nucleoside precursor.1 It has been used in the synthesis of adenosine derivatives with antiproliferative activity in human gastric cancer cells expressing the adenosine A3 receptor. 6-Chloropurine riboside has also been used in the synthesis of N6-benzyladenosine derivatives with antiproliferative activity in a variety of cancer cells or inhibitory activity against T. gondii replication in CRL-1634/Hs27 human skin fibroblasts.2,3

1.Zurita, F.V., Vega, N.B., and Cabrera, M.G.Semisynthesis, characterization and evaluation of new adenosine derivatives as antiproliferative agentsMolecules23(5)1111(2018) 2.Dolezal, K., Popa, I., HauserovÁ, E., et al.Preparation, biological activity and endogenous occurrence of N6-benzyladenosinesBioorg. Med. Chem.15(11)3737-3747(2007) 3.Kim, Y.A., Sharon, A., Chu, C.K., et al.Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agentsBiochem. Pharmacol.73(10)1558-1572(2007)

Reviews

Review for 6-Chloropurine Riboside

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 6-Chloropurine Riboside

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.